DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Naltrexone (Naltrexone Hydrochloride) - Published Studies

 
 



Naltrexone Related Published Studies

Well-designed clinical trials related to Naltrexone

Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study. [2014]

Low-dose naltrexone for the treatment of fibromyalgia: Findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels. [2013]

Effectiveness of naltrexone in the prevention of delayed respiratory arrest in opioid-naive methadone-intoxicated patients. [2013]

Naltrexone with or without guanfacine for preventing relapse to opiate addiction in St.-Petersburg, Russia. [2013]

Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels. [2013]

Evaluation of naltrexone for dissociative symptoms in borderline personality disorder. [2012.01]

Does adding low doses of oral naltrexone to morphine alter the subsequent opioid requirements and side effects in trauma patients? [2012.01]

Hepatic safety of injectable extended-release naltrexone in patients with chronic hepatitis C and HIV infection. [2012]

The combination very low-dose naltrexone-clonidine in the management of opioid withdrawal. [2012]

Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence. [2012]

Subcutaneous methylnaltrexone for treatment of acute opioid-induced constipation: phase 2 study in rehabilitation after orthopedic surgery. [2012]

A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependence. [2011.12.01]

Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence. [2011.10]

Pharmacogenetics of Naltrexone in Asian Americans: A Randomized Placebo-Controlled Laboratory Study. [2011.09.07]

Open-label pilot study of extended-release naltrexone to reduce drinking and driving among repeat offenders. [2011.09]

Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: A randomized controlled trial. [2011.07.20]

Examining naltrexone and alcohol effects in a minority population: results from an initial human laboratory study. [2011.07]

Gabapentin combined with naltrexone for the treatment of alcohol dependence. [2011.07]

Therapy with the opioid antagonist naltrexone promotes mucosal healing in active Crohn's disease: a randomized placebo-controlled trial. [2011.07]

Employment-based reinforcement of adherence to depot naltrexone in unemployed opioid-dependent adults: a randomized controlled trial. [2011.07]

Problem drinking and low-dose naltrexone-assisted opioid detoxification. [2011.05]

Safety and efficacy of methylnaltrexone in shortening the duration of postoperative ileus following segmental colectomy: results of two randomized, placebo-controlled phase 3 trials. [2011.05]

Subcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled study. [2011.05]

Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial. [2011.04.30]

A double-blind, placebo-controlled, randomized pilot study comparing quetiapine with placebo, associated to naltrexone, in the treatment of alcohol-dependent patients. [2011.03]

Effect of subcutaneous methylnaltrexone on patient-reported constipation symptoms. [2011.01]

The association between naltrexone treatment and symptoms of depression in opioid-dependent patients. [2011.01]

Does family history of alcoholism moderate naltrexone's effects on alcohol use? [2011.01]

Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial. [2011.01]

Topiramate for the treatment of alcohol dependence: comparison with naltrexone. [2011]

Adherence monitoring in naltrexone pharmacotherapy trials: a systematic review. [2011]

Characterization of abdominal pain during methylnaltrexone treatment of opioid-induced constipation in advanced illness: a post hoc analysis of two clinical trials. [2011]

Impact of intravenous naltrexone on intravenous morphine-induced high, drug liking, and euphoric effects in experienced, nondependent male opioid users. [2011]

Examining naltrexone and alcohol effects in a minority population: results from an initial human laboratory study. [2011]

Subcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled study. [2011]

Therapy with the opioid antagonist naltrexone promotes mucosal healing in active Crohn's disease: a randomized placebo-controlled trial. [2011]

Effect of subcutaneous methylnaltrexone on patient-reported constipation symptoms. [2011]

A double-blind, placebo-controlled, randomized pilot study comparing quetiapine with placebo, associated to naltrexone, in the treatment of alcohol-dependent patients. [2011]

Exploring the impact of gender and reproductive status on outcomes in a randomized clinical trial of naltrexone augmentation of nicotine patch. [2010.11.01]

Food effects on the pharmacokinetics of morphine sulfate and naltrexone hydrochloride extended release capsules. [2010.11]

A double-blind, placebo-controlled study of N-acetyl cysteine plus naltrexone for methamphetamine dependence. [2010.11]

Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: a randomized trial. [2010.10.01]

The effects of methylnaltrexone alone and in combination with acutely administered codeine on gastrointestinal and colonic transit in health. [2010.10]

A randomized trial of oral naltrexone for treating opioid-dependent offenders. [2010.09]

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. [2010.08.21]

Risk factors for craving and relapse in heroin users treated with oral or implant naltrexone. [2010.08.01]

The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trial. [2010.08]

Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis. [2010.08]

Morphine sulfate and naltrexone hydrochloride extended release capsules in patients with chronic osteoarthritis pain. [2010.07]

Human abuse liability assessment of oxycodone combined with ultra-low-dose naltrexone. [2010.07]

Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial. [2010.06.17]

A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence. [2010.06]

Relative oral bioavailability of morphine and naltrexone derived from crushed morphine sulfate and naltrexone hydrochloride extended-release capsules versus intact product and versus naltrexone solution: a single-dose, randomized-sequence, open-label, three-way crossover trial in healthy volunteers. [2010.06]

Acute HPA axis response to naltrexone differs in female vs. male smokers. [2010.05]

ALO-01 (morphine sulfate and naltrexone hydrochloride) extended-release capsules in the treatment of chronic pain of osteoarthritis of the hip or knee: pharmacokinetics, efficacy, and safety. [2010.04]

Naltrexone implants compared to methadone: outcomes six months after prison release. [2010]

Morphine sulfate and naltrexone hydrochloride extended release capsules in patients with chronic osteoarthritis pain. [2010]

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. [2010]

Risk factors for craving and relapse in heroin users treated with oral or implant naltrexone. [2010]

The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trial. [2010]

Methylnaltrexone. [2010]

Human abuse liability assessment of oxycodone combined with ultra-low-dose naltrexone. [2010]

ALO-01 (morphine sulfate and naltrexone hydrochloride) extended-release capsules in the treatment of chronic pain of osteoarthritis of the hip or knee: pharmacokinetics, efficacy, and safety. [2010]

Acute HPA axis response to naltrexone differs in female vs. male smokers. [2010]

Naltrexone for the treatment of alcohol dependence among African Americans: Results from the COMBINE Study. [2009.12.01]

Comparison of combined bupropion and naltrexone therapy for obesity with monotherapy and placebo. [2009.12]

Effects of topiramate or naltrexone on tobacco use among male alcohol-dependent outpatients. [2009.11.01]

Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness. [2009.11]

A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence. [2009.11]

Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone. [2009.10]

Extended naltrexone and broad spectrum treatment or motivational enhancement therapy. [2009.10]

High-dose naltrexone therapy for cocaine-alcohol dependence. [2009.09]

A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Naltrexone in Outpatients With Bipolar Disorder and Alcohol Dependence. [2009.08.10]

Targeted naltrexone for problem drinkers. [2009.08]

Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study. [2009.08]

Predicting the effect of naltrexone and acamprosate in alcohol-dependent patients using genetic indicators. [2009.07]

Intermittent marijuana use is associated with improved retention in naltrexone treatment for opiate-dependence. [2009.07]

Naltrexone implants after in-patient treatment for opioid dependence: randomised controlled trial. [2009.06]

Naltrexone decreases heavy drinking rates in smoking cessation treatment: an exploratory study. [2009.06]

A randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of concurrent alcohol use disorder and pathological gambling. [2009.05]

A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania. [2009.04.01]

Searching for responders to acamprosate and naltrexone in alcoholism treatment: rationale and design of the PREDICT study. [2009.04]

Very low dose naltrexone addition in opioid detoxification: a randomized, controlled trial. [2009.04]

Early outcomes following low dose naltrexone enhancement of opioid detoxification. [2009.03]

Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. naltrexone. [2009.03]

Effect of extended-release naltrexone (XR-NTX) on quality of life in alcohol-dependent patients. [2009.02]

A double-blind, placebo-controlled study of sertraline with naltrexone for alcohol dependence. [2009.01.01]

Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients. [2009.01]

Naltrexone aversion and treatment efficacy are greatest in humans and rats that actively consume high levels of alcohol. [2009.01]

Effects of alcoholism typology on response to naltrexone in the COMBINE study. [2009.01]

Effects of naltrexone on pain sensitivity and mood in fibromyalgia: no evidence for endogenous opioid pathophysiology. [2009]

Subjective effects and safety of whole and tampered morphine sulfate and naltrexone hydrochloride (ALO-01) extended-release capsules versus morphine solution and placebo in experienced non-dependent opioid users: a randomized, double-blind, placebo-controlled, crossover study. [2009]

Comparing topiramate with naltrexone in the treatment of alcohol dependence. [2008.12]

Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial. [2008.11]

Very low dose naltrexone addition in opioid detoxification: a randomized, controlled trial. [2008.08.19]

A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention. [2008.07]

Naltrexone alone and with sertraline for the treatment of alcohol dependence in Alaska natives and non-natives residing in rural settings: a randomized controlled trial. [2008.07]

Using topiramate or naltrexone for the treatment of alcohol-dependent patients. [2008.07]

Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence. [2008.07]

Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial. [2008.06.28]

Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol? [2008.06]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017